Back to Authors

Houck, Nicole

A5093087843 | I1330063522

Johnson & Johnson (United States)

Citations 3

Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis

New England Journal of Medicine | October 14, 2026 | Volume: 395 | Issue: 15 | Pages: 1495-1504

10.1056/nejmoa2604435 | PMID 42874103

P171 Efficacy and safety of icotrokinra, a targeted oral peptide that blocks il-23 receptor activation, in ulcerative colitis: results from ANTHEM-UC

E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A188-A188

10.1136/gutjnl-2026-bsg.299

O60 Icotrokinra, a targeted oral peptide that blocks IL-23 receptor activation, in moderate-to-severe ulcerative colitis: week 12 results from ANTHEM-UC

Oral Abstracts | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A38-A39

10.1136/gutjnl-2026-bsg.59